Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution.
Law, S., Brayer, G., Bromme, D.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Cathepsin K | 215 | Homo sapiens | Mutation(s): 1  Gene Names: CTSK, CTSO, CTSO2 EC: 3.4.22.38 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P43235 (Homo sapiens) Explore P43235  Go to UniProtKB:  P43235 | |||||
PHAROS:  P43235 GTEx:  ENSG00000143387  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P43235 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
1XF (Subject of Investigation/LOI) Query on 1XF | B [auth A], C [auth A], D [auth A] | 2-{[(carbamoylsulfanyl)acetyl]amino}benzoic acid C10 H10 N2 O4 S NWUAPELPCMQTDN-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 39.48 | α = 90 |
b = 60.4 | β = 95.12 |
c = 44.15 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
iMOSFLM | data reduction |
SCALA | data scaling |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
Canadian Institutes of Health Research (CIHR) | Canada | MOP-89974 |
Canadian Institutes of Health Research (CIHR) | Canada | MOP-125866 |
Canadian Institutes of Health Research (CIHR) | Canada | MOP-125866 |
Natural Sciences and Engineering Research Council (NSERC, Canada) | Canada | RGPIN-326803-13 |